$35.39
2.126.37%
Last update: Nov 9, 4:36 PM
Definium Therapeutics Inc (DFTX) Stock Price, Quote, News & History
DFTXNASDAQ
Definium Therapeutics (NASDAQ:DFTX) reported third-quarter financial results on Monday. The transcript from the company’s third-quarter earnings call has been...
You can purchase shares of Definium Therapeutics (NASDAQ:DFTX) through any online brokerage.
Other companies in Definium Therapeutics’s space includes: Eli Lilly and Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), Merck & Co Inc (NYSE:MRK), Novartis AG (NYSE:NVS) and AstraZeneca PLC (NYSE:AZN).
Definium Therapeutics has a consensus price target of $64.81.
The stock price for Definium Therapeutics (NASDAQ: DFTX) is $34.05 last updated November 9, 2026 at 4:36 PM EST.
There are no upcoming dividends for Definium Therapeutics.
Definium Therapeutics does not have any upcoming earnings scheduled.
There is no upcoming split for Definium Therapeutics.
Definium Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
Definium Therapeutics Inc is developing inventive, next-generation therapeutics intended to solve the underlying causes of psychiatric and neurological disorders and offer patients long-term remission rather than transient symptom reduction. Its...
